| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/22/2010 | US20100183729 Novel Process |
| 07/22/2010 | US20100183728 Nanoparticle comprising rapamycin and albumin as anticancer agent |
| 07/22/2010 | US20100183727 Immunonanotherapeutics that Provide IgG Humoral Response Without T-Cell Antigen |
| 07/22/2010 | US20100183726 Compositions and methods for treating cancer with dacarbazine nanoemulsions |
| 07/22/2010 | US20100183725 Multiple active pharmaceutical ingredients combined in discrete inhalation particles and formulations thereof |
| 07/22/2010 | US20100183724 Hydrogel of Chitosan Carboxyalkylamide, Preparation Thereof and Cosmetic and Dermatological Use Thereof |
| 07/22/2010 | US20100183723 Fetal Skin Cell Protein Compositions for the Treatment of Skin Conditions, Disorders or Diseases and Methods of Making and Using the Same |
| 07/22/2010 | US20100183722 Modulation of proteases. particularly in the treatment of chronic ulcerous skin lesions |
| 07/22/2010 | US20100183721 Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery |
| 07/22/2010 | US20100183720 Hetero-assembled hydrogels |
| 07/22/2010 | US20100183719 Surgical Applications for BMP Binding Protein |
| 07/22/2010 | US20100183718 Compositions and treatment of heart deficiency in non-human animals |
| 07/22/2010 | US20100183717 Controlled-release formulations |
| 07/22/2010 | US20100183716 Tableted compositions containing atazanavir |
| 07/22/2010 | US20100183715 Tableted compositions containing atazanavir |
| 07/22/2010 | US20100183714 Gastroresistant pharmaceutical dosage form comprising n-(2-(2- phthalimidoethoxy)-acetyl)-l-alanyl-d-glutamic acid (lk-423) |
| 07/22/2010 | US20100183713 Gastrointestinal-specific multiple drug release system |
| 07/22/2010 | US20100183712 Acylated indanyl amines and their use as pharmaceuticals |
| 07/22/2010 | US20100183711 Pharmaceutical compositions for reducing amyloid deposition, amyloid neurotoxicity, and microgliosis |
| 07/22/2010 | US20100183710 Omeprazole form b |
| 07/22/2010 | US20100183709 Formulation |
| 07/22/2010 | US20100183708 Antigen Delivery Vectors and Constructs |
| 07/22/2010 | US20100183707 Methods and compositions for treating hiv infection |
| 07/22/2010 | US20100183706 Peptide epitopes of apolipoprotein b |
| 07/22/2010 | US20100183705 Phospholipid-analogous compounds |
| 07/22/2010 | US20100183704 dsRNA FOR TREATING VIRAL INFECTION |
| 07/22/2010 | US20100183702 Therapies For Cancer Using RLIP76 |
| 07/22/2010 | US20100183701 Wound Dressings comprising hydrated hydrogels and enzymes |
| 07/22/2010 | US20100183700 Implantable pump for protein delivery for obesity control by drug infusion into the brain |
| 07/22/2010 | US20100183698 Methods for producing biomaterials with variable stiffness |
| 07/22/2010 | US20100183697 Tissue-separating fatty acid adhesion barrier |
| 07/22/2010 | US20100183696 Treating Ocular Diseases Using Peroxisome Proliferator-Activated Receptor Delta Antagonists |
| 07/22/2010 | US20100183695 Cerberus/coco derivatives and uses thereof |
| 07/22/2010 | US20100183692 compositions |
| 07/22/2010 | US20100183691 Use of Titanium metal fine-particles for increasing the effect of Germicidal medicines used for human skin dermatosis, skin infection and traumatism |
| 07/22/2010 | US20100183689 Making Method for Titania Nanoparticle |
| 07/22/2010 | US20100183688 Delivery System and Method of Manufacturing the Same |
| 07/22/2010 | US20100183687 Process for preparing particles of opioids and compositions produced thereby |
| 07/22/2010 | US20100183686 Method to maintain the efficacy of Orlistat |
| 07/22/2010 | US20100183685 Tumor and infectious disease therapeutic compositions |
| 07/22/2010 | US20100183582 Hemostatic compositions containing sterile thrombin |
| 07/22/2010 | US20100183515 Compositions and methods for treating the vertebral column |
| 07/22/2010 | US20100183502 Stabilized Uncoated Particles of Reversed Liquid Crystalline Phase Materials |
| 07/22/2010 | DE202009007393U1 Dragiermittel zum Dragieren von Arzneimitteln und Lebensmitteln Dragiermittel for sugarcoating of pharmaceuticals and foodstuffs |
| 07/22/2010 | CA2751884A1 Transdermal administration of tamsulosin |
| 07/22/2010 | CA2749871A1 Honey product having a low water content |
| 07/22/2010 | CA2749564A1 Unit assembly for multiple film dosages, apparatus, and methods |
| 07/22/2010 | CA2749492A1 Active coating of pharmaceutical dosage forms |
| 07/22/2010 | CA2749467A1 Porous structures with modified biodegradation kinetics |
| 07/22/2010 | CA2749401A1 Low-concentration nutritional composition |
| 07/22/2010 | CA2749245A1 A formulation for oral transmucosal administration of analgesic and/or antispasmodic molecules |
| 07/22/2010 | CA2748860A1 Hylauronic acid containing compositions for treatment of wounds, scars, post-surgical adhesion formation |
| 07/22/2010 | CA2748718A1 Ointment for the topical treatment of haemorrhoids |
| 07/22/2010 | CA2747269A1 Pharmaceutical formulation of nanonised fenofibrate |
| 07/22/2010 | CA2746856A1 Energetic nutritional composition comprising a laxative, electrolytes and carbohydrates |
| 07/22/2010 | CA2729262A1 Fenofibrate formulation with enhanced oral bioavailability |
| 07/21/2010 | EP2208705A1 Calcium secondary phosphate anhydride particle and method for producing the same |
| 07/21/2010 | EP2208496A1 Pharmaceutical formulations of potassium ATP channel openers and uses thereof |
| 07/21/2010 | EP2208495A1 Cyanoguanidine-based azole compounds useful as malonyl-CoA decarboxylase inhibitors |
| 07/21/2010 | EP2207810A1 Compositions affecting hyaluronic acid mediated activity |
| 07/21/2010 | EP2207802A2 Intranasal administration of active agents to the central nervous system |
| 07/21/2010 | EP2207534A1 Mechanical protective layer for solid dosage forms |
| 07/21/2010 | EP2207533A1 Directly compressible high functionality granular microcrystalline cellulose based excipient, manufacturing process and use thereof |
| 07/21/2010 | EP2207532A2 Pharmaceutical compositions of rhein or diacerein |
| 07/21/2010 | EP2207531A1 Self-emulsifying pharmaceutical compositions of rhein or diacerein |
| 07/21/2010 | EP2207530A2 Sustained delivery of compstatin analogs from gels |
| 07/21/2010 | EP2207529A2 Drug cores for sustained release of therapeutic agents |
| 07/21/2010 | EP2207527A2 Methods for administering corticosteroid formulations |
| 07/21/2010 | EP2207526A2 Process for the manufacure of a pharmaceutical product comprising citric acid, magnesium oxide, potassium bicarbonate and sodium picosulfate, pharmaceutical composition comprising granules obtained by such process and intermediate products thereof |
| 07/21/2010 | EP2207516A1 Device for the treatment of vaginal fungal infection |
| 07/21/2010 | EP2207507A1 Once-a-day replacement transdermal administration of fentanyl |
| 07/21/2010 | EP2114383B1 Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
| 07/21/2010 | EP2051703B1 Pharmaceutical combination comprising nucleotide and nucleoside reverse transcriptase inhibitors (such as tenofovir and lamivudine) in different parts of the dosage unit |
| 07/21/2010 | EP1790332B1 Human papilloma virus vaccine for oral administration |
| 07/21/2010 | EP1706128B1 Pharmaceutical compositions and methods for insulin treatment |
| 07/21/2010 | EP1411900B1 PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDs |
| 07/21/2010 | EP1259243B2 Bupropion metabolites and methods of their synthesis and use |
| 07/21/2010 | EP1181034B1 Combinations of immunosuppressive agents for the treatment or prevention of graft rejections |
| 07/21/2010 | EP0748228B1 powder FOR THE PROVOCATION OF AIR PASSAGE NARROWING AND/OR THE INDUCTION OF SPUTUM |
| 07/21/2010 | CN1895693B In-situ channel time formation for controlling penetrating pressure pump system |
| 07/21/2010 | CN1895361B Chinese-medicinal composition for treating gynecological inflammation and its preparation |
| 07/21/2010 | CN1876000B Preparation process of 'Yan Lu Ru Kang' pharmaceutical preparation for treating mammary gland hyperplasia |
| 07/21/2010 | CN1845723B Methods for the treatment of endometriosis |
| 07/21/2010 | CN1835870B Micronutrient supplement dispensing package which is safe to children |
| 07/21/2010 | CN1827137B Blood-activating bone-resetting capsule |
| 07/21/2010 | CN1823747B Paeonol film coated drip pill and its preparation method |
| 07/21/2010 | CN1679685B Osteopathy plaster and formulating method thereof |
| 07/21/2010 | CN101784720A Stabilized decolorizing composition |
| 07/21/2010 | CN101784288A Device for ophtalmic treatments and methods for making said device |
| 07/21/2010 | CN101784287A Aqueous composition |
| 07/21/2010 | CN101784267A Sustained-release chitosan capsules comprising chitosan and phytic acid |
| 07/21/2010 | CN101784266A bupropion hydrobromide and therapeutic applications |
| 07/21/2010 | CN101784265A Gelatin-based coatings having improved durability |
| 07/21/2010 | CN101784264A Pharmaceutical formulation for extended release |
| 07/21/2010 | CN101784263A Extended release formulation of nevirapine |
| 07/21/2010 | CN101784262A Immediate release and sustained release ibuprofen dosing regiment |
| 07/21/2010 | CN101784261A Mixtures comprising pellitorin and uses thereof |
| 07/21/2010 | CN101784260A Pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof |
| 07/21/2010 | CN101784259A Antifungal composition |
| 07/21/2010 | CN101784258A Method of producing microparticles to be ingested into the body, microparticles to be ingested into the body and dispersion and medicinal composition containing the same |